Exicure Inc.

XCUR | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.22

-$0.01 (-0.81%)

At close: Sep 21, 2026, 3:59 PM ET

$1.29

+$0.07 (+5.74%)

Pre-market: Sep 22, 2026, 8:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.81%

(1D)

Rating

Updated: Aug 22, 2026

14.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $7.78M

1D Range

1.20 1.30

52W Range

1.05 9.48

Valuation (TTM)

PE -0.93

PB 7.96

EV/EBITDA -0.71

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $12

Cash Flow

FCF Yield -82.1%

SBC Adj. FCF Yield -82.1%

SBC Impact 0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | -55.4%

Dil EPS 3Y | 5Y -15.3% | 74.2%

FCF 3Y | 5Y -24.2% | 48.3%

Returns

ROA -72.7%

ROE -237.9%

ROIC -93.9%

Financial Health

Net Cash

$1.72M

Current Ratio 0.56

Interest Coverage -7,304.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development a...

Sector Healthcare

Industry Biotechnology

Employees 8

IPO Date May 21, 2018

Website www.exicuretx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞